U.S. markets closed

Alcon Inc. (ALC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
63.18+0.17 (+0.27%)
At close: 4:00PM EST

63.18 0.00 (0.00%)
After hours: 4:17PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close63.01
Open63.13
Bid63.22 x 1000
Ask74.00 x 1400
Day's Range62.74 - 63.40
52 Week Range39.37 - 68.11
Volume388,333
Avg. Volume1,259,950
Market Cap30.855B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.47
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est67.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Alcon Inc (ALC) Q3 2020 Earnings Call Transcript
    Motley Fool

    Alcon Inc (ALC) Q3 2020 Earnings Call Transcript

    ALC earnings call for the period ending September 30, 2020.

  • Benzinga

    Alcon: Q3 Earnings Insights

    Shares of Alcon (NYSE:ALC) rose 2.73% in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share decreased 15.22% year over year to $0.39, which beat the estimate of $0.22.Revenue of $1,818,000,000 declined by 1.25% year over year, which beat the estimate of $1,670,000,000.Outlook Alcon hasn't issued any earnings guidance for the time being.View more earnings on ALCRevenue guidance hasn't been issued by the company for now.Technicals 52-week high: $68.11Company's 52-week low was at $39.37Price action over last quarter: Up 11.13%Company Description Alcon, headquartered in Fort Worth, Texas, is the global eye care leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan.See more from Benzinga * Click here for options trades from Benzinga * Earnings Scheduled For November 10, 2020 * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Alcon Reports Third Quarter 2020 Results
    Business Wire

    Alcon Reports Third Quarter 2020 Results

    Alcon Reports Third Quarter 2020 Results